Join
Live feed
·
PRReleasevia Quantisnow
Bionano Genomics Inc. logo

Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia

ByQuantisnow·Wall Street's wire, on your screen.
BNGO· Bionano Genomics Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BNGO (Bionano Genomics Inc.) and more on Quantisnow.